golvatinib
CAS: 928037-13-2
Rif. 3D-FG39270
5mg | Prezzo su richiesta | ||
10mg | Prezzo su richiesta | ||
25mg | Prezzo su richiesta |
Informazioni sul prodotto
- N-[2-Fluoro-4-[[2-[[[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl]amino]pyridin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- E-7050
- E7050
- 1,1-Cyclopropanedicarboxamide, N-[2-fluoro-4-[[2-[[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]amino]-4-pyridinyl]oxy]phenyl]-N'-(4-fluorophenyl)-
- N-(2-Fluoro-4-(2-(4-(4-methylpiperazin-1-yl)piperidine-1-carboxamido)pyridin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
Golvatinib is a potent and selective tyrosine kinase inhibitor that has been shown to have anti-angiogenic properties. In cell culture, golvatinib inhibited the proliferation of human choroidal neovascularization cells. Golvatinib also has potential as a prognostic biomarker for solid tumours. This drug is poorly soluble in water, but it can be dissolved in glycol ethers such as diethyleneglycol dimethyl ether. Golvatinib binds to epidermal growth factor receptors with high affinity and specificity, which leads to inhibition of phosphorylation and activation of downstream signalling pathways.
Proprietà chimiche
Richiesta tecnica su: 3D-FG39270 golvatinib
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.